Skip to main content
. Author manuscript; available in PMC: 2007 Oct 22.
Published in final edited form as: Lancet. 2007 Mar 24;369(9566):1016–1026. doi: 10.1016/S0140-6736(07)60461-9

Table 6.

Incremental cost-effectiveness ratios—cost per QALY

Cost (£) QALYs Incremental
cost (£)
Incremental
QALYs
Incremental cost-effectiveness
ratio (£ per QALY)
Valproate 1390 1·648 .. .. ..
Topiramate 1568 1·809 178  0·161 1106
Lamotrigine 1906 1·701 338 −0·108 Dominated